Trials / Recruiting
RecruitingNCT05126160
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
Immune Score Based Radiomics in Nasopharyngeal Carcinoma (IMRAN Study)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 494 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
In nasopharyngeal carcinoma (NPC), tumor, node and metastasis (TNM) staging system is the main tool for determining treatment strategy and assessment of prognosis. However, the prognoses of patients with the same TNM stage after similar treatment vary widely. The aim of this study is to establish an immune score based radiomic staging system for NPC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Immune Score Based Radiomics | To establish an immune score based radiomic staging system for nasopharyngeal carcinoma |
Timeline
- Start date
- 2021-11-05
- Primary completion
- 2022-10-01
- Completion
- 2027-12-01
- First posted
- 2021-11-18
- Last updated
- 2021-11-18
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05126160. Inclusion in this directory is not an endorsement.